Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P01275 (
glucagon
)
26,492
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Various forms of cross-talk between the Ca2+ and cAMP signal transduction systems can occur in animal cells depending upon the types of adenylyl cyclases present. Here, we report that Ca2+ oscillations can be generated by hormone stimulation of
type III adenylyl cyclase
expressed in HEK-293 cells. These Ca2+ oscillations are apparently due to the unique regulatory features of
type III adenylyl cyclase
, which is stimulated by hormones and inhibited by elevated Ca2+ in vivo. Ca2+ oscillations were generated by
glucagon
, isoproterenol, or forskolin stimulation of
type III adenylyl cyclase
and were dependent upon the activity of cAMP- and calmodulin-dependent protein kinases. Ca2+ oscillations were not solely dependent upon cAMP increases since dibutyryl cAMP or (Sp)-cAMP did not stimulate Ca2+ oscillations. We hypothesize that stimulation of
type III adenylyl cyclase
leads to increased cAMP, activation of inositol 1,4,5-trisphosphate receptors, and elevation of intracellular Ca2+. As free Ca2+ increases,
type III adenylyl cyclase
activity is attenuated by CaM kinase(s) and intracellular cAMP levels decrease. When cAMP levels drop below a threshold level, the inositol 1,4,5-trisphosphate receptor is dephosphorylated and Ca2+ is resequestered. This cycle is repeated if
type III adenylyl cyclase
is chronically exposed to an activator. This unique mechanism for generation of Ca2+ oscillations in cells is distinct from others documented in the literature.
...
PMID:Hormone stimulation of type III adenylyl cyclase induces Ca2+ oscillations in HEK-293 cells. 759 12
Type III adenylyl cyclase is stimulated by beta-adrenergic agonists and
glucagon
in vitro and in vivo, but not by Ca2+ and calmodulin. However, the enzyme is stimulated by Ca2+ and calmodulin in vitro when it is concomitantly activated by the guanyl nucleotide stimulatory protein Gs (Choi, E. J., Xia, Z., and Storm, D. R. (1992a) Biochemistry 31, 6492-6498). Here, we examined regulation of
type III adenylyl cyclase
by Gs-coupled receptors and intracellular Ca2+ in vivo. Surprisingly, intracellular Ca2+ inhibited hormone-stimulated
type III adenylyl cyclase
activity. Submicromolar concentrations of intracellular free Ca2+, which stimulated type I adenylyl cyclase, inhibited
glucagon
- or isoproterenol-stimulated
type III adenylyl cyclase
. Inhibition of
type III adenylyl cyclase
by intracellular Ca2+ was not mediated by Gi, cAMP-dependent protein kinase, or protein kinase C. However, an inhibitor of CaM kinases antagonized Ca2+ inhibition of the enzyme, and coexpression of constitutively activated CaM kinase II completely inhibited isoproterenol-stimulated
type III adenylyl cyclase
activity. We propose that Ca2+ inhibition of
type III adenylyl cyclase
may serve as a regulatory mechanism to attenuate hormone-stimulated cAMP levels in some tissues.
...
PMID:Ca2+ inhibition of type III adenylyl cyclase in vivo. 766 59